MCID: HYP017
MIFTS: 43

Hypophosphatemia malady

Category: Metabolic diseases

Aliases & Classifications for Hypophosphatemia

About this section

Aliases & Descriptions for Hypophosphatemia:

Name: Hypophosphatemia 11 27 50 13 68

Classifications:



External Ids:

Disease Ontology11 DOID:0050336

Summaries for Hypophosphatemia

About this section
Wikipedia:71 Hypophosphatemia is an electrolyte disturbance in which there is an abnormally low level of phosphate in... more...

MalaCards based summary: Hypophosphatemia is related to cutaneous-skeletal hypophosphatemia syndrome and dominant hypophosphatemia with nephrolithiasis or osteoporosis. An important gene associated with Hypophosphatemia is FGF23 (Fibroblast Growth Factor 23), and among its related pathways are Transcription_Role of VDR in regulation of genes involved in osteoporosis and Development_Hedgehog and PTH signaling pathways in bone and cartilage development. The drugs ergocalciferol and sodium phosphate, dibasic have been mentioned in the context of this disorder. Affiliated tissues include bone, liver and kidney, and related mouse phenotypes are limbs/digits/tail and renal/urinary system.

Related Diseases for Hypophosphatemia

About this section

Diseases related to Hypophosphatemia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 166)
idRelated DiseaseScoreTop Affiliating Genes
1cutaneous-skeletal hypophosphatemia syndrome12.1
2dominant hypophosphatemia with nephrolithiasis or osteoporosis11.8
3hypophosphatemic rickets, x-linked dominant11.7
4hypophosphatemic rickets, autosomal dominant11.5
5hereditary hypophosphatemic rickets11.4
6hypophosphatemic rickets, ar11.3
7nephrolithiasis/osteoporosis, hypophosphatemic, 111.3
8hypophosphatemic rickets, autosomal recessive, 211.3
9hypophosphatemic rickets11.2
10panostotic fibrous dysplasia11.1
11oncogenic osteomalacia11.0
12hypophosphatemic rickets with hypercalciuria10.9
13vitamin d-dependent rickets, type i10.8
14tumoral calcinosis, hyperphosphatemic, familial10.7
15exostoses, multiple, type 110.7
16fanconi renotubular syndrome 110.7
17nephrolithiasis/osteoporosis, hypophosphatemic, 210.7
18dent disease10.7
19metaphyseal chondrodysplasia, murk jansen type10.7
20lowe syndrome10.7
21autosomal recessive hypophosphatemic rickets10.7
22wiedemann-steiner syndrome10.3FGF23, PHEX
23ventricular tachycardia, catecholaminergic polymorphic, 310.2DMP1, FGF23
24keratoderma with woolly hair10.2SLC34A1, SLC34A3
25feigenbaum bergeron richardson syndrome10.2FGF23, PHEX
26acute maxillary sinusitis10.2DMP1, FGF23, PHEX
27epilepsy, idiopathic generalized 1410.2BGLAP, FGF23
28familial atrial fibrillation10.2ENPP1, FGF23, PHEX
29deafness, nonsyndromic, modifier 110.2CLCN5, SLC34A3
30childhood absence epilepsy10.1ENPP1, FGF23, PHEX
31maroteaux stanescu cousin syndrome10.1BGLAP, FGF23, PHEX
32orbit lymphoma10.1FGF23, PTH
33juvenile onset parkinson disease 19a10.1BGLAP, ENPP1
34rickets10.1
35newborn respiratory distress syndrome10.1CLCN5, SLC34A1, SLC34A3
36hepatitis10.1
37waardenburg syndrome, type 4b10.1PTH, SLC34A1
38hypochondrogenesis10.1BGLAP, PTH
39toxicodendron dermatitis10.1BGLAP, PTH
40y chromosome detection10.1BGLAP, PTH
41anorexia nervosa10.1
42hip dysplasia, beukes type10.1DMP1, DSPP
43high-grade dysplasia in patients with barrett esophagus10.1BGLAP, CLCN5, SLC34A3
44weill-marchesani syndrome10.0FGF23, PTH, SLC34A1
45osteomalacia10.0
46adult ependymoblastoma10.0BGLAP, PTH
47x-linked hereditary ataxia10.0DMP1, ENPP1, FGF23, PHEX
48adermatoglyphia10.0DMP1, DSPP
49mesenchymal cell neoplasm10.0BGLAP, PTH
50interstitial nephritis10.0CLCN5, PTH, SLC34A1

Graphical network of the top 20 diseases related to Hypophosphatemia:



Diseases related to hypophosphatemia

Symptoms & Phenotypes for Hypophosphatemia

About this section

MGI Mouse Phenotypes related to Hypophosphatemia according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053719.6DMP1, FGF23, PHEX, PTH, SFRP4
2MP:00053678.0CLCN5, DMP1, ENPP1, FGF23, PHEX, SFRP4
3MP:00053787.6CLCN5, DMP1, ENPP1, FGF23, PHEX, PTH
4MP:00053767.6CLCN5, DMP1, ENPP1, FGF23, PHEX, PTH
5MP:00053906.3CLCN5, DMP1, ENPP1, FGF23, MEPE, PHEX

Drugs & Therapeutics for Hypophosphatemia

About this section

Drugs for Hypophosphatemia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 82)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
IronapprovedPhase 4, Phase 2, Early Phase 111657439-89-623925
Synonyms:
02583_FLUKA
12310_ALDRICH
12310_RIEDEL
129048-51-7
14067-02-8
161135-39-3
190454-13-8
195161-83-2
199281-22-6
209309_ALDRICH
209309_SIAL
255637_ALDRICH
266213_ALDRICH
266256_ALDRICH
267945_ALDRICH
267953_ALDRICH
26Fe
338141_ALDRICH
356808_ALDRICH
356824_ALDRICH
356832_ALDRICH
39344-71-3
3ZhP
413054_ALDRICH
443783-52-6
44890_ALDRICH
44890_FLUKA
675141-17-0
70884-35-4
73135-38-3
7439-89-6
8011-79-8
8053-60-9
AC1L2N38
ATW 230
ATW 432
Ancor B
Ancor en 80/150
Armco iron
Atomel 28
Atomel 300M200
Atomel 500M
Atomel 95
Atomiron 44MR
Atomiron 5M
Atomiron AFP 25
Atomiron AFP 5
C00023
C3518_SIAL
C3518_SIGMA
CCRIS 1580
CHEBI:18248
CID23925
Carbonyl iron
Copy Powder CS 105-175
D007501
DB01592
DSP 1000
DSP 128B
DSP 135
DSP 135C
DSP 138
Diseases (animal), iron overload
Diseases, iron overload
EF 1000
EF 250
EFV 200/300
EFV 250
EFV 250/400
EINECS 231-096-4
 
Ed-In-Sol
Eisen
Electrolytic iron
F 60 (metal)
FE
FT 3 (element)
Fe
Fe-40
Fe1+
Feronate
Ferretts
Ferro-Caps
Ferro-Time
Ferrousal
Ferrovac E
Ferrum
Ferrum metallicum
GS 6
HF 2 (element)
HL (iron)
HQ (metal)
HS (iron)
HS 4849
HSDB 604
Hemocyte
Hierro
Hoeganaes ATW 230
Hoeganaes EH
IRMM524A_FLUKA
IRMM524B_FLUKA
IRON
Iron (Fe)
Iron (Fe1+)
Iron ion (Fe+)
Iron ion(1+)
Iron monocation
Iron powder
Iron standard for AAS
Iron(1+)
Iron(1+) ion
Iron(III) nitrate solution
Iron, carbonyl
Iron, electrolytic
Iron, elemental
Iron, ion (Fe1+)
Iron, ion (Fe1+) (8CI,9CI)
Iron, reduced
LOHA
LS-3196
MolPort-003-925-001
NC 100
PZh-1M3
PZh-2
PZh1M1
PZh2M
PZh2M1
PZh2M2
PZh3
PZh3M
PZh4M
PZhO
Reduced iron
Remko
SUY-B 2
Siderol
UNII-E1UOL152H7
Vitedyn-Slo
Yieronia
fer
ferrous iron
hierro
2Ferric CompoundsPhase 4, Phase 2194
3Pharmaceutical SolutionsPhase 4, Phase 28192
4Trace ElementsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 16001
5MicronutrientsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 16001
6HematinicsPhase 4, Phase 21684
7
Ergocalciferolapproved, nutraceuticalPhase 3128150-14-65280793
Synonyms:
'Ergosterol irradiated'
(+)-Vitamin D2
(3-beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10,(19),22-tetraen-3-ol
(3S,5Z,7E,14xi,17alpha,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol
(3beta,5Z,7E,22E)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(3beta,5Z,7e,22e)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
(5E,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7E,22E)-(3S)-9,10-secoergosta-5,7,10(19),22-tetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Seco-5,7,10(19),22-ergostatetraen-3-ol
(5Z,7e,22e)-(3S)-9,10-Secoergosta-5,7,10(19),22-tetraen-3-ol
22-Tetraen 3beta 9,10,Secoergosta-5,7,10(19)-ol
31316-19-5
4-Methylene-3-[2-[tetrahydro-7a-methyl-1-(1,4,5-trimethyl-2-hexenyl)-4(3aH)-indanylidene]ethylidene]-Cyclohexanol
47768_SUPELCO
50-14-6
7489-18-1
7E677DC1-E1C4-4FC5-8F4A-BCE1857F7E87
8017-28-5
9,10,Secoergosta-5,7,10(19),22-tetraen 3.beta.-ol
9,10-Seco(5Z,7E,22E)-5,7,10(19),22-ergostatetraen-3-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3-beta-ol
9,10-Secoergosta-5,7,10(19),22-tetraen-3b-ol
95220_FLUKA
95220_SIGMA
AC-1355
AC1L1FIE
AC1NQXLH
AC1NS4DE
AC1NS9GI
AC1NSSVD
AC1NWAM3
AC1O5EDK
AC1O6WAM
ACon1_002187
Activated ergosterol
BPBio1_000418
BSPBio_000380
BSPBio_001974
Buco-D
C05441
C28H44O
CALCIFEROL IN A GELATIN MATRIX
CALCIFEROL, U.S.P.
CHEBI:28934
CHEMBL1536
CID11003810
CID3249
CID5280793
CID5315257
CID5353610
CID5356615
CID5702050
CID6432478
CID6536972
Calciferol
Calciferol (TN)
Calciferol (vitamin D2)
Calciferolum
Calciferon 2
Condacaps
Condocaps
Condol
Crtron
Crystallina
D-Arthin
D-Tracetten
D00187
DB00153
Daral
Davitamon D
Davitin
De-rat concentrate
Decaps
Dee-Osterol
Dee-Ron
Dee-Ronal
Dee-Roual
Deltalin
Deratol
Detalup
Diactol
Divit urto
Doral
Drisdol
Drisdol (TN)
E5750_SIGMA
EINECS 200-014-9
Ercalciol
Ergocalciferol
Ergocalciferol (D2)
Ergocalciferol (JP15/USP)
Ergocalciferol [INN:BAN:JAN]
Ergocalciferol oil
Ergocalciferol: Vitamin D
 
Ergocalciferolo
Ergocalciferolo [DCIT]
Ergocalciferols
Ergocalciferolum
Ergocalciferolum [INN-Latin]
Ergorone
Ergosterol activated
Ergosterol irradiated
Ergosterol, irradiated
Ertron
Fortodyl
Geltabs
Geltabs Vitamin D
HMS1920K20
HMS2091B19
HMS502I07
HSDB 819
Haliver
Hi-Deratol
Hyperkil
I05-0022
IDI1_000805
Infron
Irradiated ergosta-5,7,22-trien-3-beta-ol
Irradiated ergosta-5,7,22-trien-3.beta.-ol
Irradiated ergosta-5,7,22-trien-3beta-ol
Irradiated ergosterol
LMST03010001
LMST03010014
LS-3228
MEGxm0_000466
MLS001332467
MLS001332468
Metadee
Mina D2
MolPort-001-740-057
MolPort-001-793-930
MolPort-002-526-645
MolPort-003-666-178
MolPort-006-822-629
Mulsiferol
Mykostin
NCGC00142497-01
NCGC00179579-01
NCGC00179579-02
NSC 62792
NSC62792
Novovitamin-D
Oleovitamin D
Oleovitamin D, Synthetic
Oleovitamin D2
Osteil
Ostelin
Prestwick3_000420
Prestwick_554
Radiostol
Radstein
Radsterin
Rodine C
Rodinec
SMR000857106
SPECTRUM1500276
ST057150
STOCK1N-53397
Shock-ferol
Shock-ferol sterogyl
Sorex C.R
Sorex C.R.
Spectrum5_000666
Sterogyl
Synthetic Vitamin D
UNII-VS041H42XC
Uvesterol D
Uvesterol-D
VITAMIN D2
VITAMIN D2 WATER DISPERSABLE U.S.P.
VITAMIN_D2
Vigantol
Vio D
Vio-D
Viostdrol
Viosterol
Viosterol in Oil
Vitamin D2
Vitamin- D2
Vitamin-?D2
Vitamina D2
Vitavel-D
WLN: L56 FYTJ A1 BY1&1U1Y1&Y1&1 FU2U- BL6YYTJ AU1 DQ
ZINC04474571
ZINC04629876
beta-Ol
bmse000510
component of Geltabs Vitamin D
delta-Arthin
delta-Tracetten
ergocalciferol
vitamin d-2
8vitamin dPhase 31724
9VitaminsPhase 3, Phase 15282
10Calcimimetic AgentsPhase 3, Phase 171
11Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 3, Phase 1, Phase 213168
12Cinacalcet HydrochloridePhase 3, Phase 171
13HormonesPhase 3, Phase 1, Phase 214415
14Hormone AntagonistsPhase 3, Phase 1, Phase 213180
15Calcium, DietaryPhase 3, Phase 1, Phase 2, Early Phase 15713
16MitogensPhase 3, Phase 2, Phase 11617
17ErgocalciferolsPhase 31281
18Bone Density Conservation AgentsPhase 3, Phase 1, Early Phase 13376
19ImmunoglobulinsPhase 3, Phase 26394
20Immunoglobulin GPhase 3, Phase 2275
21Antibodies, MonoclonalPhase 3, Phase 24039
22AntibodiesPhase 3, Phase 26394
23Vitamin D2NutraceuticalPhase 31281
24CalciferolNutraceuticalPhase 31383
25
LenalidomideapprovedPhase 2736191732-72-6216326
Synonyms:
1-oxo-2-(2,6-Dioxopiperidin-3-yl)-4-aminoisoindoline
191732-72-6
3-(4-Amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione
3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione
3-(7-Amino-3-oxo-1H-isoindol-2-yl)-piperidine-2,6-dione
3-(7-amino-3-oxo-1H-isoindol-2-yl)piperidine-2,6-dione
346670-73-3
443912-14-9
AC-914
AC1L50II
AKOS005146276
ALBB-015321
Bio-0168
C467567
CC 5013
CC-5013
CC-5013, Revlimid, Lenalidomide
CC5013
CDC 501
CDC-501
CDC-5013
CHEMBL848
CID216326
Celgene brand of lenalidomide
D04687
 
DB00480
EC-000.2340
ENMD-0997
I06-0831
IMID-1
IMID-5013
IMiD3
IMiD3 cpd
IMid-1
LS-184040
Lenalidomide
Lenalidomide (USAN/INN)
Lenalidomide [USAN]
MolPort-003-848-370
NCGC00167491-01
NSC747972
Revamid
Revimid
Revlimid
Revlimid (Celgene)
Revlimid (TN)
S1029_Selleck
STK639603
Thalidomide analog CC-5013
UNII-F0P408N6V4
lenalidomide
26
CetuximabapprovedPhase 2752205923-56-456842117, 2333
Synonyms:
205923-56-4
Anti EGFR
Cetuximab
Cetuximab (USAN/INN)
Cetuximab (genetical recombination)
Cetuximab (genetical recombination) (JAN)
 
Cetuximabum
Cétuximab
D03455
Erbitux
Erbitux (TN)
IMC-C225
Immunoglobulin G 1 (human-mouse monoclonal C 225 gamma 1 - chain anti-human epidermal growt factor receptor), disulfide wit human-mouse monoclonal C 225 kappa - chain, dimer
cetuximab
27
Tenofovirapproved, investigationalPhase 2759147127-20-6464205
Synonyms:
(R)-9-(2-Phosphonomethoxypropyl)adenine
(R)-9-(2-Phosphonylmethoxypropyl)adenine
(R)-9-(2-phosphonomethoxypropyl)adenine
(R)-PMPA
147127-20-6
206184-49-8
AC-760
AC1LA9BO
Anh. tenofovir
Anhydrous tenofovir
Apropovir
CHEBI:45809
CHEMBL483
CID464205
D,L-Tenofovir
DB00300
GNA & Tenofovir
GS 1275
GS 1278
GS1278
 
HHA & Tenofovir
KS-5021
MolPort-003-850-411
NCGC00167535-01
PMPA
PMPA-(R)
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Galanthus nivalis agglutinin (GNA)
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Hippeastrum hybrid agglutinin( HHA)
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- (9CI)
Phosphonic acid, [[2-(6-amino-9H-purin-9
S1401_Selleck
TDF
TFV
Tenefovir
Tenofovir
Tenofovir (anh.)
Tenofovir disoproxil
Tenofovir disoproxil fumarate
UNII-99YXE507IL
Viread
Viread, Tenofovir
[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid
28Protective AgentsPhase 27443
29potassium phosphatePhase 2, Phase 111
30AnticoagulantsPhase 22623
31DextransPhase 2104
32Cariostatic AgentsPhase 2333
33Iron-Dextran ComplexPhase 275
34Blood SubstitutesPhase 2253
35Plasma SubstitutesPhase 2240
36Angiogenesis InhibitorsPhase 24257
37Immunosuppressive AgentsPhase 213086
38Anti-Bacterial AgentsPhase 211226
39Angiogenesis Modulating AgentsPhase 24185
40Anti-Infective AgentsPhase 222062
41Anti-HIV AgentsPhase 23162
42Anti-Retroviral AgentsPhase 23296
43Antiviral AgentsPhase 29967
44Nucleic Acid Synthesis InhibitorsPhase 24962
45Reverse Transcriptase InhibitorsPhase 21913
46Phosphorus SupplementNutraceuticalPhase 1, Phase 24
47
Sorafenibapproved, investigationalPhase 1700284461-73-0216239, 406563
Synonyms:
284461-73-0
4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide
4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide
4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic acid methyamide-4-methylbenzenesulfonate
4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide
4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide
4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE
AB1004622
AC-1674
AC1L50CF
BAX
BAY 43-9006
BAY 43-9006 (free base)
BAY 43-9006 tosylate salt
BAY 439006
BAY 54-9085 (tosylate salt)
BAY-43-0006
BAY-43-9006
BAY-54-9085
BAY43-9006
BRD-K23984367-001-01-8
Bio-0100
CHEBI:47228
CHEBI:50924
CHEMBL1336
CID216239
 
D08524
DB00398
DB07438
EN002709
I06-0856
K00597a
Kinome_766
LS-186067
LS-187021
LS-187788
MolPort-003-850-270
N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
N-(4-Chloro-3-(trifluoromethyl)phenyl)-n'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea
N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea
N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea
NCGC00167488-01
NSC-724772
NSC747971
Nexavar
STK627350
Sorafenib
Sorafenib (INN)
Sorafenib [INN]
Sorafenib tosylate
Sorafenibum
UNII-9ZOQ3TZI87
ZINC01493878
nchembio.117-comp17
sorafenib
sorafenibum
48
DenosumabapprovedPhase 1138615258-40-7
Synonyms:
615258-40-7
AMG-162
D03684
Denosumab
 
Denosumab (USAN)
Denosumab (genetical recombination)
Denosumab (genetical recombination) (JAN)
Prolia
Xgeva
49
Nicotinamideapproved, NutraceuticalPhase 191998-92-0936
Synonyms:
.beta.-Pyridinecarboxamide
11032-50-1
123574-63-0
1yc5
3 Pyridinecarboxamide
3-Carbamoylpyridine
3-Pyridinecarboxamide
3-Pyridinecarboxylic acid amide
37321-14-5
47865U_SUPELCO
55600-01-6
63748-44-7
72340_FLUKA
72340_SIGMA
72347_FLUKA
78731-47-2
98-92-0
A186B02E-6C70-4E54-9739-79398D439AAA
AC-907/25014114
AC1L1ACZ
AC1Q4ZFV
AI3-02906
Acid amide
Amid kyseliny nikotinove
Amid kyseliny nikotinove [Czech]
Amide PP
Aminicotin
Amixicotyn
Amnicotin
Astra Brand of Niacinamide
Austrovit PP
B 3, Vitamin
B3, Vitamin
BB_NC-2290
Benicot
C00153
C6H6N2O
CCRIS 1901
CHEBI:17154
CHEMBL1140
CID936
CPD000058212
D00036
D009536
DB02701
DEA No. 1405
Delonin Amide
Delonin amide
Dipegyl
Dipigyl
EINECS 202-713-4
EINECS 234-265-0
Endobion
Enduramide
Factor pp
HMS2052M21
HMS2090B05
HMS2093H03
HSDB 1237
Hansamid
I02-1741
I02-2250
InChI=1/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9
Inovitan PP
Jenapharm Brand of Niacinamide
Jenapharm, Nicotinsaureamid
LS-2051
MLS000069714
Mediatric
Merck Brand of Niacinamide
MolMap_000061
MolPort-001-783-876
N0078
N0636_SIGMA
N2142_SIGMA
N3376_SIGMA
N5535_SIAL
NAM
NCGC00093354-03
NCGC00093354-04
NSC 13128
NSC13128
NSC27452
Nandervit-N
Niacevit
Niacinamide
Niacinamide (USP)
Niacinamide Astra Brand
Niacinamide Jenapharm Brand
Niacinamide Merck Brand
 
Niacinamide Pharmagenix Brand
Niacinamide [USAN]
Niacinamide, Nicotinic acid amide, Nicotinamide
Niacotinamide
Niamide
Niavit PP
Nicamide
Nicamina
Nicamindon
Nicasir
Nicobion
Nicofort
Nicogen
Nicomidol
Nicosan 2
Nicosylamide
Nicota
Nicotamide
Nicotilamide
Nicotililamido
Nicotinamid
Nicotinamida
Nicotinamida [INN-Spanish]
Nicotinamide
Nicotinamide (JP15/INN)
Nicotinamide (Niacinamide)
Nicotinamide, niacin, vitamin B3
Nicotinamide-carbonyl-14C
Nicotinamidum
Nicotinamidum [INN-Latin]
Nicotine acid amide
Nicotine amide
Nicotinic acid amide
Nicotinic amide
Nicotinsaeureamid
Nicotinsaureamid
Nicotinsaureamid Jenapharm
Nicotinsaureamid [German]
Nicotol
Nicotylamide
Nicotylamidum
Nicovel
Nicovit
Nicovitina
Nicovitol
Nicozymin
Nictoamide
Nikasan
Nikazan
Niko-tamin
Nikotinamid
Nikotinsaeureamid
Nikotinsaeureamid [German]
Niocinamide
Niozymin
PP-Faktor
Papulex
Pelmin
Pelmine
Pelonin amide
Pharmagenix Brand of Niacinamide
Propamine A
Pyridine-3-carboxylic acid amide
S1899_Selleck
SAM001246860
SGCUT00176
SMR000058212
Savacotyl
UNII-25X51I8RD4
Vi-Nicotyl
Vi-noctyl
Vitamin B
Vitamin B (VAN)
Vitamin B 3
Vitamin B3 amide
Vitamin H1
Vitamin PP
WLN: T6NJ CVZ
Witamina PP
ZINC00005878
b-Pyridinecarboxamide
beta-Pyridinecarboxamide
bmse000281
m-(Aminocarbonyl)pyridine
nchembio.154-comp4
nchembio.73-comp6
niacin - Vitamin B3
niacinamide
nicotinamide
pyridine-3-carboxamide
to_000073
vitamin PP
50
Folic Acidapproved, nutraceutical, vet_approvedPhase 1439259-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10

Interventional clinical trials:

(show all 44)
idNameStatusNCT IDPhase
1The Effect of a Diet Based on Low Sodium and Slowly Absorbed Carbohydrates on the Incidence of Refeeding Syndrome in Patients With Head and Neck CancerUnknown statusNCT01845922Phase 4
2A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or MonoferRecruitingNCT02905539Phase 4
3Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic RicketsCompletedNCT00417612Phase 3
4Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant RecipientsCompletedNCT00975000Phase 3
5Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic RicketsCompletedNCT01237288Phase 3
6Efficacy and Safety of KRN23 Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With X Linked Hypophosphatemia (XLH)RecruitingNCT02915705Phase 3
7Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH)Active, not recruitingNCT02526160Phase 3
8Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)Active, not recruitingNCT02537431Phase 3
9Hypophosphatemia With Intravenous Ferric Carboxymaltose Versus Iron Dextran in Women With Iron Deficiency Secondary to Heavy Uterine BleedingUnknown statusNCT01307007Phase 2
10Investigating a New Way of Giving Medicine to Newborn and Preterm BabiesUnknown statusNCT01676844Phase 2
11An Extension Study of KRN23 in Adults With X-Linked HypophosphatemiaCompletedNCT01571596Phase 1, Phase 2
12A Repeated Study of KRN23 in Adults With X-Linked HypophosphatemiaCompletedNCT01340482Phase 1, Phase 2
13Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative MenCompletedNCT00131677Phase 2
14Cetuximab and Lenalidomide in Head and NeckCompletedNCT01133665Phase 2
15Growth Hormone Treatment in Children With Hypophosphatemic RicketsCompletedNCT02720770Phase 1, Phase 2
16Role Of Phosphorus And FGF 23 In Patients With Dent DiseaseRecruitingNCT02016235Phase 1, Phase 2
17Study of KRN23, a Recombinant Fully Human Monoclonal Antibody Against FGF23, in Pediatric Subjects With X-linked Hypophosphatemia (XLH)Active, not recruitingNCT02163577Phase 2
18Study of the Safety, Pharmacodynamics and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)Active, not recruitingNCT02750618Phase 2
19Long-Term Extension Study of KRN23 in Adult Subjects With X-Linked Hypophosphatemia (XLH)Enrolling by invitationNCT02312687Phase 2
20Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic RicketsUnknown statusNCT00473187Phase 1
21Effect of Cinacalcet on Parathyroid Hormone Secretion in Children and Adolescents With Hypophosphatemic RicketsUnknown statusNCT00195936Phase 1
22A Study of KRN23 in X-linked HypophosphatemiaCompletedNCT00830674Phase 1
23Multiple Dose Study to Evaluate the Safety of Multiple Doses of Denosumab 120 mg in Adults With Severe Chronic Kidney Disease (CKD) and CKD on DialysisCompletedNCT01464931Phase 1
24A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/OsteomalaciaCompletedNCT02181764Phase 1
25Mechanistic Evaluation on Sorafenib Induced Hypophosphatemia.TerminatedNCT00622479Phase 1
26Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)TerminatedNCT01748812Phase 1
27Using Cinacalcet to Treat the Hypophosphatemia of Early Kidney TransplantUnknown statusNCT01011114
28Perspective Evaluation of Hormones Involved in Serum Phosphate Homeostasis in Patients With Metastatic Renal Cells Carcinoma or Hepatocellular Carcinoma Treated With Sorafenib (SORHORM)Unknown statusNCT01230697
29Calcimimetics in Hypophosphatemic RicketsUnknown statusNCT00844740
30Calcitonin for Treating X-linked HypophosphatemiaCompletedNCT01652573
31FGF-23 Suppressibility by CalcitoninCompletedNCT00688077
32Does Intravenous Iron Therapy Decrease Serum Phosphorous Levels?CompletedNCT02420119
33A Prospective Cohort Study to Describe the Evolution of Persistent Hyperparathyroidism in Kidney Transplant RecipientsCompletedNCT01163669
34Serum Calcium to Phosphorous Ratio (Ca/P) as a Simple, Inexpensive Screening Tool in the Diagnosis of Primary HyperparathyroidismCompletedNCT03027349
35Effect of Dietary Protein Source on Phosphaturia, PTH and FGF23 in Patients With CKD 3 and 4CompletedNCT00764816
36Effect of the Consumption of Ferric Hydroxide Adipate on Urinary Phosphorus Excretion.CompletedNCT01991574Early Phase 1
37Leptin, IGF1 and the Refeeding IndexCompletedNCT01227850
38Studying Phosphorus MetabolismCompletedNCT00066183
39Catheterization to Locate Mesenchymal Tumors in Patients With Tumor-Induced Osteomalacia or Oncogenic OsteomalaciaCompletedNCT00099762
40Assessment Of Vitamin D Role In The Pathogenesis Of Asthma In Vitamin D Resistent PatientsCompletedNCT01578824
41Observing the Changes of Fibroblast Growth Factor 23 in Patients of Tumor Induced OsteomalaciaRecruitingNCT01660308
42Refeeding Syndrome Among Older AdultsRecruitingNCT03141489
43Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.RecruitingNCT02233322
44Hypophosphatemic Rickets in NorwayActive, not recruitingNCT01057186

Search NIH Clinical Center for Hypophosphatemia

Inferred drug relations via UMLS68/NDF-RT46:

Show with subtypes

Genetic Tests for Hypophosphatemia

About this section

Genetic tests related to Hypophosphatemia:

id Genetic test Affiliating Genes
1 Hypophosphatemia27

Anatomical Context for Hypophosphatemia

About this section

MalaCards organs/tissues related to Hypophosphatemia:

36
Bone, Liver, Kidney, Skeletal muscle, Prostate, Myeloid, Breast

Publications for Hypophosphatemia

About this section

Articles related to Hypophosphatemia:

(show top 50)    (show all 596)
idTitleAuthorsYear
1
Corn-Soy-Blend Fortified with Phosphorus to Prevent Refeeding Hypophosphatemia in Undernourished Piglets. (28081252)
2017
2
Hypophosphatemia predicts a failure to recover from adefovir-related renal injury after dose reduction in lamivudine-resistant hepatitis B patients. (28079295)
2017
3
Hypophosphatemia in Users of Cannabis. (27692442)
2017
4
Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemia. (27884786)
2017
5
Minimally Invasive Surgical Management of Thoracic Ossification of the Ligamentum Flavum Associated with X-linked Hypophosphatemia. (27481600)
2016
6
Hypophosphatemia in Enterally Fed Patients in the Surgical Intensive Care Unit: Common but Unrelated to Timing of Initiation or Aggressiveness of Nutrition Delivery. (27562444)
2016
7
Hypophosphatemia and recovery of post-hepatectomy liver insufficiency. (27275463)
2016
8
Hypophosphatemia-induced Cardiomyopathy. (27650239)
2016
9
Good's syndrome and hypoparathyroidism combined with hypocalcaemia, hypokalemia, hypomagnesemia, and hypophosphatemia-Case report. (26875773)
2016
10
Two Cases of Hypophosphatemia with Increased Renal Phosphate Excretion in Legionella Pneumonia. (27066493)
2016
11
Hypophosphatemia as a novel etiology of Brugada Phenocopy. (26828385)
2016
12
FGFR Inhibitor Ameliorates Hypophosphatemia and Impaired Engrailed-1/Wnt Signaling in FGF2 High Molecular Weight Isoform Transgenic Mice. (26762209)
2016
13
CRISPR/Cas9-mediated mutation of PHEX in rabbit recapitulates human X-linked hypophosphatemia (XLH). (27126636)
2016
14
Hypertension is a characteristic complication of X-linked hypophosphatemia. (28025445)
2016
15
Incidence of hypophosphatemia in advanced cancer patients: a recent report from a single institution. (27832387)
2016
16
Identifying the culprit lesion in tumor induced hypophosphatemia, the solution of a clinical enigma. (27709474)
2016
17
Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment. (27497815)
2016
18
Hypophosphatemia promotes lower rates of muscle ATP synthesis. (27338702)
2016
19
Targeting the ligand in hypophosphatemia. (27885013)
2016
20
Preventing/treating hypophosphatemia by adding phosphate to the dialysate. (26689145)
2016
21
Zoledronate Induced Hypocalcemia and Hypophosphatemia in Osteoporosis: A Cause of Concern. (27113952)
2016
22
Drug-specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions. (27859495)
2016
23
Two Case Reports of FGF23-Induced Hypophosphatemia in Childhood Biliary Atresia. (27462066)
2016
24
Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia. (27894323)
2016
25
Poster 282 Functional Gains after Diagnosis of Central Pontine Myelinolysis due to Hypophosphatemia in a Leukemia Patient on an Acute Inpatient Rehabilitation Unit: A Case Report. (27673041)
2016
26
A Case of Hypophosphatemia with Increased Urinary Excretion of Phosphorus Associated with Ibrutinib. (27194982)
2016
27
Tenofovir disoproxil fumarate-associated hypophosphatemia as determined by fractional excretion of filtered phosphate in HIV-infected patients. (27613487)
2016
28
Hypophosphatemia in Critically Ill Children: Risk Factors, Outcome and Mechanism. (27392619)
2016
29
Effect of hypophosphatemia on the withdrawal of mechanical ventilation in patients with acute exacerbations of chronic obstructive pulmonary disease. (27073623)
2016
30
Quiz Page September 2016: Multiple Myeloma and Hypophosphatemia. (27561668)
2016
31
Hypercalcemia and hypophosphatemia in a 11 years old girl with ovarian tumor. (27837927)
2016
32
An Institutional Change in Continuous Renal Replacement Therapy: Nutrition Support Team Resolves Resultant Severe Hypophosphatemia. (27589256)
2016
33
Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms. (26783348)
2016
34
Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk. (27907058)
2016
35
Serum FGF23 levels may not be associated with serum phosphate and 1,25-dihydroxyvitamin D levels in patients with Fanconi syndrome-induced hypophosphatemia. (27679714)
2016
36
A Case of Severe, Prolonged, Refractory Hypophosphatemia After Zoledronic Acid Administration. (26739479)
2016
37
Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy. (27444071)
2016
38
Phosphate and Vitamin D Prevent Periodontitis in X-Linked Hypophosphatemia. (27821544)
2016
39
A computationally identified compound antagonizes excess FGF-23 signaling in renal tubules and a mouse model of hypophosphatemia. (27879395)
2016
40
Clinical outcome of critically ill patients with thrombocytopenia and hypophosphatemia in the early stage of sepsis. (27834985)
2016
41
FGF23 Neutralizing Antibody Ameliorates Hypophosphatemia and Impaired FGF Receptor Signaling in Kidneys of HMWFGF2 Transgenic Mice. (27306296)
2016
42
Fibroblast Growth Factor 23 and Hypophosphatemia: A Case of Hypophosphatemia along the Rickets-Osteomalacia Spectrum. (27994603)
2016
43
Hypophosphatemia, Hypomagnesemia, and Hypokalemia in Pediatric Patients Before and During Exclusive Individualized Parenteral Nutrition. (26869613)
2016
44
Conditional Deletion of Murine Fgf23: Interruption of the Normal Skeletal Responses to Phosphate Challenge and Rescue of Genetic Hypophosphatemia. (26792657)
2016
45
A radiological study on intra- and extra-cranial calcifications in adults with X-linked hypophosphatemia and associations with other mineralizing enthesopathies and childhood medical treatment. (26913700)
2016
46
Incidence and Clinical Outcome of Hypophosphatemia in Pediatric Burn Patients. (27380125)
2016
47
Predictors of hypophosphatemia during refeeding of patients with severe anorexia nervosa. (25846384)
2015
48
Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia. (26073451)
2015
49
Prolonged hypophosphatemia following parathyroidectomy in chronic hemodialysis patients. (26354572)
2015
50
Risk factors for refeeding hypophosphatemia in Japanese inpatients with anorexia nervosa. (26446402)
2015

Variations for Hypophosphatemia

About this section

Expression for genes affiliated with Hypophosphatemia

About this section
Search GEO for disease gene expression data for Hypophosphatemia.

Pathways for genes affiliated with Hypophosphatemia

About this section

Pathways related to Hypophosphatemia according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.6BGLAP, PTH
29.6BGLAP, PTH
39.3BGLAP, FGF23, PTH

GO Terms for genes affiliated with Hypophosphatemia

About this section

Cellular components related to Hypophosphatemia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1endoplasmic reticulum lumenGO:00057889.7BGLAP, DMP1, FGF23, MEPE
2vesicleGO:00319829.4BGLAP, SLC34A1, SLC34A3
3extracellular regionGO:00055767.2BGLAP, DMP1, DSPP, ENPP1, FGF23, MEPE

Biological processes related to Hypophosphatemia according to GeneCards Suite gene sharing:

(show all 22)
idNameGO IDScoreTop Affiliating Genes
1response to sodium phosphateGO:190438310.5FGF23, PHEX
2response to magnesium ionGO:003202610.5FGF23, SLC34A1
3response to growth hormoneGO:006041610.5PHEX, SLC34A1
4phosphate ion transmembrane transportGO:003543510.4SLC34A1, SLC34A3
5phosphate ion transportGO:000681710.4SLC34A1, SLC34A3
6bone mineralizationGO:003028210.4BGLAP, PHEX
7response to cadmium ionGO:004668610.4PTH, SLC34A1
8response to lead ionGO:001028810.3PTH, SLC34A1
9response to parathyroid hormoneGO:007110710.3PTH, SLC34A1
10negative regulation of bone mineralizationGO:003050210.3FGF23, MEPE
11cellular response to parathyroid hormone stimulusGO:007137410.3FGF23, PHEX, SLC34A1
12phosphate ion homeostasisGO:005506210.2FGF23, SFRP4, SLC34A1
13cellular response to vitamin DGO:007130510.1BGLAP, FGF23, PHEX
14phosphate-containing compound metabolic processGO:000679610.0ENPP1, FGF23
15response to vitamin DGO:00332809.9BGLAP, PHEX, PTH
16sodium-dependent phosphate transportGO:00443419.8SLC34A1, SLC34A3
17cellular protein metabolic processGO:00442679.7DMP1, FGF23, MEPE, SLC34A1
18regulation of bone mineralizationGO:00305009.5BGLAP, ENPP1, FGF23
19cellular phosphate ion homeostasisGO:00306439.4ENPP1, FGF23, SLC34A1, SLC34A3
20ossificationGO:00015039.4BGLAP, DMP1, DSPP, SLC34A1
21skeletal system developmentGO:00015018.4BGLAP, DSPP, MEPE, PHEX, PTH
22biomineral tissue developmentGO:00312148.1BGLAP, DMP1, DSPP, ENPP1, MEPE, PHEX

Molecular functions related to Hypophosphatemia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1sodium-dependent phosphate transmembrane transporter activityGO:001532110.1SLC34A1, SLC34A3
2sodium:phosphate symporter activityGO:00054369.8SLC34A1, SLC34A3

Sources for Hypophosphatemia

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet